menu search

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Encouraging preliminary data from a phase 2 trial evaluating io102-io103 in combination with pembrolizumab for first-line treatment of patients with non-small cell lung cancer and squamous cell carcin

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 23, 2023, 5:00 am

Crescent communities announces the sale of two communities to ta realty

novel Harpeth Heights and novel Cary continue to see imm...

October 19, 2023, 6:22 pm

Bitcoin-centric ai language model aims to drive btc education and adoption

novel AI language model Spirit of Satoshi trained on Bitcoin-related resources aims to drive education ...

October 19, 2023, 3:15 pm

Yunhong green cti ltd. to host third quarter 2023 conference call on november 2nd

LAKE BARRINGTON, IL / ACCESSWIRE / October 19, 2023 / Yunhong Green CTI Ltd. (NASDAQ:YHGJ) (the "Company") a leading manufacturer of custom film packa...

October 19, 2023, 9:00 am

Ultragenyx announces pricing of public offering of common stock and pre-funded warrants

NOVATO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developme...

October 19, 2023, 1:16 am

Sagimet biosciences to present at the h.c. wainwright 7th annual nash investor conference

SAN MATEO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing ...

October 18, 2023, 4:05 pm

Hookipa pharma announces publication of preclinical data of hepatitis b virus (hbv) therapeutic vaccine developed in collaboration with gilead sciences

HB-400, a novel arenaviral therapeutic vaccine, generates robust T cell responses specific to hepatitis...

October 18, 2023, 11:01 am

Preclinical data demonstrate anti-siglec-15 treatment reduced bone loss and enhanced bone quality in mice with moderate-to-severe osteogenesis imperfecta (oi)

Data Presented at the 2023 American Society for Bone and Mineral Research (ASBMR) Annual Meeting BELTSVILLE, Md., Oct. 17, 2023 (GLOBE NEWSWIRE) — N...

October 17, 2023, 12:05 pm

Southern co. (so), novelis partner to build two solar plants

Southern Co.'s (SO) unit, Alabama Power, and Novelis join forces to build 80-MW solar plants, aiding decarbonization and supporting the latter's carbo...

October 17, 2023, 10:32 am

Sellas life sciences to present final data from phase 1/2 study of galinpepimut-s in combination with keytruda® (pembrolizumab) in patients with wt1+ platinum-resistant advanced ovarian cancer at the

NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS'' or the “Company”), a late-stage clinical b...

October 17, 2023, 8:45 am

Zymeworks to host third quarter 2023 results conference call

VANCOUVER, British Columbia, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel,...

October 17, 2023, 8:30 am

7 cutting-edge stocks that could change humanity as we know it

They say we're now living in an “age of acceleration” when technological advances are coming at us at breakneck speed. Not long ago, science ficti...

October 16, 2023, 6:16 pm

Andrew varga’s debut novel named as finalist in 2024 forest of reading

The Last Saxon King nominated for the Red Maple Award (Grades 7-8) LAS VEGAS, Oct. 16, 2023 (GLOBE NEWSWIRE) — Imbrifex Books, an independent publis...

October 16, 2023, 4:00 pm

Modifi bio raises additional $4.3 million in seed funding

Financing will drive the further development of a new class of drugs targeting DNA repair defects in cancer. NEW HAVEN, Conn., Oct. 16, 2023 (GLOBE NE...

October 16, 2023, 11:00 am

Masimo (masi) gets de novo for novel oxygen status index ori

Masimo's (MASI) ORi parameter gets De Novo from the FDA, providing option for continuous monitoring of oxygen level in surgical patients leading to be...

October 16, 2023, 8:16 am

Biontech to present multiple program updates across modalities at esmo congress 2023

MAINZ, Germany, October 16, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data across its oncology pipeline, c...

October 16, 2023, 3:30 am

Arvinas and pfizer announce upcoming vepdegestrant (arv-471) poster presentation at esmo congress 2023

NEW HAVEN, Conn. and NEW YORK, Oct. 15, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced they will p...

October 15, 2023, 10:05 pm


Search within

Pages Search Results: